Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check7 days agoChange DetectedNo additions or deletions are present in the change history data. The page content remains unchanged from the previous version.SummaryDifference0.0%

- Check14 days agoChange DetectedThe history shows a new site revision from v3.6.5 to v3.6.6. This indicates a deployment with minor fixes or improvements that do not change study information.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedA new revision entry, v3.6.5, is added to the record history, replacing the previous v3.6.4. This indicates a software release update to the page rather than changes to trial data or content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe footer revision label updated from v3.6.3 to v3.6.4. This reflects a new build of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check72 days agoChange DetectedThe footer revision updated from v3.6.2 to v3.6.3. This represents a minor site/template update and does not alter page content.SummaryDifference0.0%

- Check78 days agoChange DetectedA new release entry, Revision: v3.6.2, has been added to the study record history and the older Revision: v3.6.0 entry has been removed. This updates the documented software version reflected on the page.SummaryDifference0.0%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.